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Abstract
Background: SPECT/CT combines high resolution anatomical 3D computerized tomography (CT) and single
photon emission computerized tomography (SPECT) as functional imaging, which provides 3D information about
biological processes into a single imaging modality. The clinical utility of SPECT/CT imaging has been recognized in
a variety of medical fields and most recently in orthopaedics; however, clinical adoption has been limited due to
shortcomings of analytical tools available. Specifically, SPECT analyses are mainly qualitative due to variation in
overall metabolic uptake among patients. Furthermore, most analyses are done in 2D, although rich 3D data are
available. Consequently, it is difficult to quantitatively compare the position, size, and intensity of SPECT uptake
regions among patients, and therefore difficult to draw meaningful clinical conclusions.
Methods: We propose a method for normalizing orthopaedic SPECT/CT data that enables standardised 3D
volumetric quantitative measurements and comparison among patients. Our method is based on 3D localisation
using clinically relevant anatomical landmarks and frames of reference, along with intensity value normalisation
using clinically relevant reference regions. Using the normalised data, we describe a thresholding technique to
distinguish clinically relevant hot spots from background activity.
Results: Using an exemplar comparison of two patients, we demonstrate how the normalised, 3D-rendered data
can provide a richer source of clinical information and allow quantitative comparison of SPECT/CT measurements
across patients. Specifically, we demonstrate how non-normalized SPECT/CT analysis can lead to different clinical
conclusions than the normalized SPECT/CT analysis, and that normalized quantitative analysis can be a more
accurate indicator of pathology.
Conclusions: Conventional orthopaedic frames of reference, 3D volumetric data analysis and thresholding are used
to distinguish clinically relevant hot spots from background activity. Our goal is to facilitate a standardised
approach to quantitative data collection and comparison of clinical studies using SPECT/CT, enabling more
widespread clinical use of this powerful imaging tool.
Background
SPECT/CT combines a high resolution anatomical 3D
computerized tomography (CT) and a single photon
emission computerized tomography (SPECT) as func-
tional imaging, which provides 3D information about
biological processes into a single imaging modality.
Along with the fusion of these images the metabolic
activity in a region of interest can be accurately
allocated to specific anatomical areas [1-3]. Until
recently, registration of the functional images (SPECT)
with the structural images (CT) has been difficult due
to SPECT’s poor spatial resolution (3-10 mm) and its
high variability in identifying anatomical landmarks
[4,5]. With the advent of integrated SPECT/CT tech-
nology, where the SPECT data is obtained in the same
coordinate frame as the CT, image fusion has signifi-
cantly improved [6].
Although SPECT/CT has proven useful as a diagnostic
tool in a variety of medical fields and most recently in
orthopaedics [1,7-11], its use has a number of limitations.
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individual patient investigated and cannot easily be com-
pared between patients. Therefore, it is difficult to draw
clinically useful conclusions on intensity and size of
SPECT regions. Several authors have introduced methods
of quantification of SPECT data to minimize subjective
tracer interpretation, however to date no quantitative
analysis has been described in orthopaedic patients
[12-16]. Secondly, although 3D-data are generally
obtained, analysis is routinely performed only in 2D (ROI
analysis) [11]. Thirdly, accurate and reproducible locali-
zation of increased or decreased tracer uptake in 3D is
difficult to achieve [10,11]. Fourthly, to date clinical cor-
relation of the biology, the biomechanics and the func-
tion of joint pathology has not been sufficiently studied
in orthopaedics.
Enhanced tracer uptake regions
The pattern and intensity (increased, decreased) of tracer
distribution in a SPECT scan gives information on bone
and soft tissue pathologies. Radionuclide tracers are cho-
sen that preferentially bind to a specific metabolic activity
(e.g., technetium-labeled diphosphonate for osseous
activity), and injected intravenously 3-4 hours before the
SPECT and CT imaging. Regions of increased tracer
uptake (which we term a “hotspot”) may signal a metabo-
lically active region and provide a diagnostic aid. Current
analysis, however, is limited to this relative comparison
(increased or decreased) as opposed to quantifying the
intensity of the tracer uptake region in a clinically signifi-
cant way.
A key hurdle is the significant inter- and intra-patient
variation in the metabolic uptake of radionuclide tracers.
Variation of more than 10 times in the average SPECT
intensity is not uncommon between patients. Because of
this variation, it is difficult to identify a clinically relevant
SPECT intensity threshold to distinguish regions of inter-
ests from normal background variation.
Methods
The purpose of this paper is to propose a method to
normalize the 1) location, 2) size, and 3) intensity of
altered tracer uptake regions to allow quantitative com-
parison of orthopaedic SPECT/CT scans. Our method
uses standardized orthopaedic frames of reference for
orientation, and 3D volumetric data interpretation and
thresholding to distinguish clinically relevant hot spots
from background activity. Along with its introduction
we strive to facilitate data collection and comparison of
clinical studies using SPECT/CT. In this section we pre-
sent the normalization method details. We then provide
an exemplar patient comparison as a demonstration of
the method’s use in the Results.
Data analysis
The proposed normalization techniques and analysis can
be carried out with any software that can reorient 3D
data and quantify intensities of the SPECT voxels. We
have implemented the software tools necessary for the
exemplar patient comparison using a collection of open-
source tools. The software was written in Python (v2.6,
http://python.org/), using the Grassroots DICOM library
(GDCM v2.0.12, http://gdcm.sourceforge.net/) to read
the SPECT and CT DICOM files exported by the
SPECT/CT machine, the Visualisation Toolkit (VTK
v5.4.2, Kitware, http://vtk.org/) library for surface and
volume rendering, and the NumPy (http://numpy.scipy.
org/) Python library for data analysis. Note that a slight
modification was required to the GDCM library to over-
come an idiosyncrasy in the SPECT DICOM data for
t h es p e c i f i cS P E C T / C Tm a c h i n eu s e d( S y m b i aT 1 6 ,
Siemens).
Normalisation of position: orthopaedic reference frames
To reliably locate and describe the position of a region of
altered metabolic activity it is essential that the reference
system is well defined. Further, to overcome the relative
position and orientation of the patient to the coordinate
system of the scanner, the reference system should be
based on anatomic landmarks that are identifiable in sub-
sequent scans. The unique combination of anatomic and
metabolic information available with SPECT/CT imaging
allows the low resolution metabolic information from
SPECT to be accurately localised using the high resolu-
tion anatomic information from CT.
We use well-recognised standard anatomic landmarks
and corresponding frames of reference that relate to the
biomechanics of the joint. The landmarks can be manually
identified on a combination of CT slices and on the sur-
face of a 3D bone reconstruction from the CT data. These
landmarks define a coordinate system specific to the lower
limb, independent of scanner-specific coordinates. We can
then use this normalised coordinate system to localize the
biomechanical and diagnostic SPECT regions of interest.
Further, with this normalised coordinate system we can
provide normalised views for the 3D bone reconstruction
and 2D slices (i.e., “true” antero-posterior views and slices
that will be the same perspective relative to the anatomy
independent of the patient position and orientation in the
scanner).
The femoral frame of reference is defined as contain-
ing the mechanical axis of the femur and the axis of
rotation of the knee, with the origin at the centre of the
joint (Figure 1). This frame of reference gives the ante-
roposterior axis and the mediolateral axis of the femur
[17]. The midpoint of a straight line joining the surface
locations of the epicondyles is taken as the centre of the
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Page 2 of 10knee. We use the femoral head centre as the proximal
landmark defining the mechanical orientation of the
femur. This point is defined as the intersection of the
diameters of the head in all three planes. The mechani-
cal axis of the femur is then defined as the line passing
from the centre of the femoral head to the centre of the
knee. We establish an orthogonal reference frame using
the cross product of the transepicondylar line and the
mechanical axis to define the anteroposterior axis, and
the cross product of the anteroposterior axis and the
mechanical axis to define the mediolateral axis.
The tibial orthogonal reference frame is constructed
to treat the knee as a simple hinge, so that tibial sagittal
planes are the same as the femoral sagittal planes
(Figure 2). Specifically, the mediolateral axis is taken to
be the same as the femoral medioateral axis, the antero-
posterior axis is defined as the cross product of the
mediolateral axis and the line between the knee centre
(as defined above) proximally and the centre of the talus
distally, and the mechanical axis as the cross product
between mediolateral axis and the anteroposterior axis.
Figure 1 Femoral anatomic reference frame.T h ef e m u ri s
aligned to an anatomic reference frame, independent of patient
position in the scanner, using the mechanical axis determined by
the femoral head centre and the centre of the knee defined by the
medial and lateral femoral epicondyles. This reference frame
provides slice alignment and 3D reconstruction views that are the
same for multiple scans of the same patient, as well as comparable
views for different patients.
Figure 2 Tibial anatomic reference frame. The tibia is aligned
similar to the femur, treating the knee joint as a simple hinge. The
centre of the talus is used as a distal landmark.
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reference region
Here we propose a method for normalising the SPECT
intensities between patients to allow for quantitative analy-
sis, potentially increasing the value of SPECT imaging.
Direct comparison of raw SPECT intensities is known to
be problematic, due to significant variation among patients
in overall uptake levels. Normalisation techniques that rely
purely on the distribution of SPECT intensities, such as
scaling by the maximum value, or normalising using the
mean and standard deviation, are also problematic. These
techniques can be biased by the fraction of tissue related
voxels as compared to free air voxels (affected by patient
size and field of view), the presence of an intense hotspot,
or an overall inflammatory uptake response.
What we propose is to use the anatomic information
provided by the CT component to establish, prior to ana-
lysis, a clinically relevant neutral region. For example,
when analysing intensities relating to knee joint pain, we
can define a volume in the middle of the femoral shaft
(which is unrelated to the articular surface) as a reference
region. The distribution of SPECT intensities from this
region can be then be used to normalize other values. This
approach avoids the biases associated with patient size,
field of view, and normalising solely on the global distribu-
tion of SPECT intensities. It also takes advantage of the
unique combination of anatomic and metabolic informa-
tion offered by SPECT/CT imaging.
The optimal method to normalize hotspot intensities
using reference region intensities, resulting in an analysis
with the best correlation with clinical outcomes, remains
an open research question and likely depends on the spe-
cific analysis conducted. Potential approaches include scal-
ing intensities to the mean of the reference region,
offsetting intensities with the mean of the reference region,
using the standard deviation of the values in the reference
region as a scaling parameter, or some combination of
these techniques. Hotspots can then be compared in a sta-
tistical manner, using a t-test to compare the distribution
of values in a hotspot with the values in the reference
region. Intensity thresholds can also be defined in a
straightforward way, such as more than n standard devia-
tions away from the reference region mean.
Thresholding for volumetric 3D tracer uptake analysis
and visualisation
Having established clinically relevant intensity thresholds
using the method described above, we can use threshold-
ing (an algorithmically simple operation) to distinguish
altered tracer uptake voxels from background voxels.
This avoids the difficult segmentation procedure nor-
mally associated with quantitative analysis of medical
images. The threshold also enables simple volumetric
analysis within a region. For example, one can use a
rectangular volume (which is straightforward to define)
to define an initial region, then use the threshold to dis-
tinguish altered tracer uptake voxels from background
voxels within the region (Figure 3).
This clinically relevant intensity also defines a bound-
ary for the 3D surface reconstruction (i.e., isosurface ren-
dering) of the SPECT region of interest (Figure 4). The
SPECT region boundary surface can be rendered with
the 3D bone surface reconstruction, enabling views from
any perspective including the normalized views described
above. This can aid the clinician’s understanding of the
position of the uptake region, which is of particular use
when informing a surgical procedure.
Results
Here we present an exemplar analysis of SPECT/CT
scans of two patients presented to our hospital, demon-
strating the establishment of orthopaedic frames of refer-
ence, the localisation of SPECT tracer uptake regions, the
normalisation of the intensities (based on the intensities
in a neutral region in the femoral shaft) and a quantita-
tive comparison of the size and intensity of the SPECT
voxels in patients with symptomatic patellofemoral joints.
Patient description
Both patients presented to our hospital complaining
about knee pain with the history and clinical examination
suggestive of patellofemoral disease. We decided to
demonstrate the proposed method on these two patients
Figure 3 Thresholding for analysing SPECT data.U s i n ga
threshold cutoff combined with an easy-to-use rectangular region
selector allows for straightforward identification of hotspot voxels
for further analysis.
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comes to the patellofemoral joint. Both patients have
been diagnosed with patellofemoral osteoarthritis, but
show a different distribution of osteoarthritis. In one the
cause is considerably a slight trochlear dysplasia and the
other one is idiopathic.
SPECT/CT imaging
For both patients, Tc-99m-HDP-SPECT/CT was per-
formed using a hybrid system (Symbia T16, Siemens,
Erlangen, Germany) that consists of a pair of low energy,
high-resolution collimators and a dual-head gamma cam-
era and an integrated 16x0.75-mm slice-thickness CT. A
commercial 700 MBq Tc-99m HDP tracer (CIS Bio Inter-
national Sur Yvette, France) was used. SPECT imaging
was performed at 3-4 hours post injection, followed by a
CT without moving the patient. In addition, 2D perfusion
images were obtained in the initial 60 seconds post injec-
tion followed by 2D blood pool images 2-5 minutes later.
Non-normalized analysis and visualisation
Initial SPECT renderings (threshold SPECT voxels at
90% of maximum intensity) show similar tracer uptake
patterns, in particular the size and intensity of the
altered tracer uptake region (Figure 5), indicating iso-
lated patellofemoral disease in both patients. However,
thresholding at a lower value (60% of maximum) reveals
a different uptake extent. At this lower threshold, P2’s
uptake region extents into the tibiofemoral joint, while
P1’s hotspot is localized within the patellofemoral joint
only. Without a normalization procedure to inform a
clinically relevant threshold, it is difficult to determine
whether P2’s observed uptake is part of normal physio-
logical variation in tracer uptake or is an indication of
pathology.
Normalisation of position: orthopaedic reference frames
The femur and tibia of both SPECT/CT datasets were
reoriented into the normalised (anatomic-based) refer-
ence frames described above. Note that for P2, this
resulted in a realignment of the femur of more than 5
degrees, an important correction if the scanner-based
reference frame was used for orthopaedic measurements
(Figure 6). All following figures of slices and reconstruc-
tions are presented in the normalised perspectives (e.g.,
“true” AP and lateral views).
Normalisation of size and intensity: clinically neutral
reference region
We used a region in the middle of the femur to estab-
lish a clinically neutral reference region (Figure 7). The
SPECT intensities within this neutral region were then
used as a baseline distribution from which we could
compare the SPECT intensities on the articular surfaces.
For this comparison, we used three times the average
intensity in the reference region to signify a clinically
relevant level of increased tracer activity. (Again, the
clinically optimal relationship between the reference
region, the hotspot and clinical outcomes remains an
area of active research.)
Clinical implications
Using the above determined normalized threshold, we
were able to analyze and re-render the SPECT data at
Figure 4 Rendering SPECT region of interest. Once a clinically relevant SPECT intensity threshold has been established, we can render a
hotspot surface at that threshold for a visual appreciation of the hotspot size and position.
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(Figure 8). This rendering supports the clinical diagnosis
of isolated patellofemoral disease in P1 and bi-compart-
mental disease in P2. Comparison of the intensities of
the maximum value in the region of interest against the
intensity of the reference region further supported the
conclusion of P2’s increased degeneration. P1’sm a x i -
mum was less intense (4.55 times the mean reference
intensity) than P2’s (5.56 times the mean reference
intensity). Similarly, comparing the mean value of the
region of interest (using four times the mean of the
reference region to focus on the patellofemoral hotspot
in each patient) revealed that P1’s mean was less intense
(P1: 4.19 vs. P2: 4.49) (Figure 9). Finally, comparing the
number of SPECT voxels above the clinical threshold
show that P2’s uptake region is larger in size (volume)
than P1’s.
Discussion
We have proposed a novel method of standardized quan-
titative volumetric 3D-analysis of SPECT/CT imaging to
overcome the limitations of qualitative 2D analysis. A
standardised approach to quantitative volumetric 3D data
collection using SPECT/CT enabling analysis of the size,
the intensity and the localisation of enhanced tracer
uptake regions of SPECT/CT, that we put forward as
“hotspot”, was introduced. The major contributions of
our method are the following:
1. Standardised 3D-CT reconstructions using relevant
surgical anatomical landmarks are used to define
Figure 5 Non-normalized SPECT renderings. Renderings of the SPECT uptake region for patient 1 (left column) and patient 2 (right column)
at 90% maximum SPECT intensity (top row) and 60% maximum SPECT intensity (bottom row). Without a method to identify a clinically relevant
threshold intensity, drawing clinical conclusions is problematic.
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orientation [18]. Only after orientation of the data in
relation to the mechanical axis of the lower limb can
reliable and meaningful information be drawn for the
diagnosis and treatment of patients with musculoskeletal
disorders [11,19-21]. To our knowledge the proposed
method offers for the first time the chance to relate the
information of joint mechanics (CT) with clinical hot-
spots as biologic/metabolic data (SPECT).
Current imaging and image processing techniques are
not sufficiently advanced to investigate certain patholo-
gies and compartments of joints. The patellofemoral dis-
ease is one such condition, which is difficult to
differentiate from the other two compartments of the
knee. In addition, it is a typical example for the symbio-
sis of joint mechanics and biology. This is also relevant
for patients following joint replacement surgery
[11,18,20,21]. This 3D localisation method enables the
surgeon to more clearly identify the clinically relevant
hotspots and aid in understanding of the origin of the
patient’s symptoms.
2. It is widely known that individual SPECT hotspots
vary greatly among patients. The normalizing techni-
ques described here allow comparison of quantitative
measurements amongst different patients. It may con-
tribute to the understanding of pathologies and clinical
value in clinical trials using SPECT/CT [11,20,22,23].
Figure 6 Patient 2 femur before and after realignment.B e f o r e
(left) and after (right) realignment of patient 2 femur to anatomic
based reference frame. Note change of more than 5 degrees in
axial alignment.
Figure 7 SPECT intensities in reference region and region of interest. Comparison of the tracer uptake intensities in the region of interest
(right column) relative to the intensities in a reference region (middle column) for patient 1 (top row) and patient 2 (bottom row). The SPECT
histograms (left column) illustrate SPECT tracer distribution of the reference region ("saved”) in comparison to the SPECT region of interest
("local”) and the whole dataset ("global”).
Hirschmann et al. BMC Medical Imaging 2012, 12:5
http://www.biomedcentral.com/1471-2342/12/5
Page 7 of 10Using our proposed method of image analysis and pro-
cessing we hope to distinguish clinically relevant hot-
spots from normal background activity. Normalization
approaches are biased by the patient size, the field of
view and metabolic activity in areas outside the region
of clinical interest [11]. The establishment of clinically
neutral reference regions prior to analysis addresses
t h e s ep r o b l e m s .T h el i m i t a t i o n so ft h ec o n v e n t i o n a l
approach to SPECT data normalisation, which relies on
the distribution of SPECT intensities, scaling by the
maximum values or normalisation using the mean or
standard deviation are also avoided. However, the opti-
mal method to normalize hotspot intensities using
reference region intensities is an open research ques-
tion. It may depend on different methods of data analy-
sis [11,20,22,23]. The optimal approach to scaling of
intensities has to be investigated in clinical studies. We
suggest studies looking into the normalisation of hot-
spots and offsetting intensities with the mean of the
reference region. Using the standard deviation of the
values in the reference region as a scaling parameter or
some combination of these techniques might also be
helpful to improve diagnostics further [21]. Hotspots
c a nt h e nb ec o m p a r e di nas t a t i s t i c a lm a n n e rt oc o m -
pare the distribution of values within a hotspot with
that of the reference region. Intensity thresholds can
also be defined as a factor of the standard deviation
from the reference region mean.
Figure 9 SPECT uptake region analysis. Using a higher threshold
(four times the mean of the reference region) showed a higher
value for patient 2’s uptake region (bottom figure, upper patellar
pole) as compared to patient 1, (top figure, lower patellar pole).
Figure 8 3D reconstructions of SPECT and bone surface.T h e
SPECT hot spots are demonstrated at our chosen SPECT threshold
(three times mean of the reference region) as a 3D surface
reconstruction (left) and radiolucent (right) views (patient 1 top,
patient 2 bottom row).
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novel and contrasts previous clinical studies using
SPECT or SPECT/CT in orthopaedics, where the SPECT
intensity and size of hotspots was graded using a Likert
scale (0-10) or descriptively analysed [11,20-23]. To date,
most authors consider the area of maximum tracer activ-
ity as the area of interest analysing the peak values only
[11,21]. However, this method neglects the lower inten-
sity SPECT values and may lead to a decrease in sensitiv-
ity and specificity in specific clinical conditions. It may
also be case that the pattern of uptake provides the sur-
geon with more clinically relevant information leading to
a more accurate diagnosis.
Conclusions
We propose a standardized method of analysing the
location, size and the intensity of SPECT/CT tracer
uptake regions ("hotspots”). Conventional orthopaedic
frames of reference, 3D volumetric data analysis and
thresholding are used distinguish clinically relevant hot
spots from background activity. We demonstrated how
the normalised, 3D-rendered data may provide a richer
source of clinical information and allow quantitative
comparison of SPECT/CT measurements across
patients. This article gives a detailed description on the
proposed method, but its clinical utility will be investi-
gated in further clinical studies.
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